Table 5.
Peptide (sequence) | Conjugates | Bacteria/Fungus % biofilm Inhibition | Reference |
---|---|---|---|
G3 GIIKKIIKKIIKKI‐ NH2 |
Ser‐Galactose and Caprylic acid | Inhibition of P. aeruginosa biofilm in 71% at 2xMIC | [330] |
CGA‐N9 RILSILRHQ |
N‐octanoic | Inhibition of C. albicans biofilm formation in 50.5 µg mL−1 | [331] |
FKKL | G2 PAMAM dendrimer | Inhibition of E. coli biofilm formation ofapproximately 98% | [332] |
III5 Sequence no reported |
2‐heptamine | Inhibition of MRSA biofilms in 80% at 128 µg mL−1 | [333] |
E6 RRWRIVVIRVRRC‐NH2 | Polydopamine | Inhibition of P. aeruginosa biofilms in 98.4% | [334] |
C10‐KR8d KRIWQRIK |
C10 Acyl‐chain | Inhibition of S. aureus USA300 LAC biofilm in 100% | [335] |
Mur‐B WRGITKVVKKV |
myristoyl moiety | Inhibition of C. albicans, C. tropicalis, and C. auris isolates at128 µg mL−1 | [239] |
C12‐DK5 IKKILSKIKKLL‐NH2 |
CH3(CH2)10C(O)‐ | Inhibitory concentration that reduced S. aureus and C. albicans biofilm development at 6.25 µg mL−1 | [336] |
LyeTxI‐b IWLTALKFLGKNLGKLAKQQKAKL |
Acetyl | Inhibition of S. aureus biofilm at 46 µmol/L | [337] |
CT9W1000 Sequence no reported |
PEG | Inhibition of P. aeruginosa PAO1 biofilms at 2×MIC | [338] |
PEG6‐IDR1018 VRLIVAVRIWRR‐NH2 |
PEG | Inhibition of MRSA0017 biofilms in 90% at 64 µg mL−1 | [339] |
L163 Ac‐FLPLIGGLLKGLL‐NH2 |
Acetyl | It inhibited the formation of MDR S. aureus, Streptococcus suis, and L. monocytogenes biofilms. | [331] |